APL accounts for 10–15% of AML cases and is characterized by t(15;17)(q24;21), which leads to fusion of the promyelocytic leukaemia (PML) gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17 [5]. Here, RARA is linked to acute myeloid leukemia.